NASH

NASH

Displaying 10 out of 8 results

  1. A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California

    Gilead experimental NASH drug fails another study

    Gilead Sciences Inc said on Thursday its experimental drug to treat scarring of tissue due to nonalcoholic steatohepatitis (NASH) did not meet ...
  2. New Content Item

    Gilead teams up with insitro for experimental NASH treatments

  3. A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California

    Gilead misses key goal in NASH liver disease trial, shares sink

    Gilead Sciences Inc said on Monday that a late-stage study of a key experimental drug aimed at treating NASH, a progressive fatty liver disease, ...
  4. Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche buys US biotech Jecure in race for liver disease drugs

    Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat ...
  5. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis, Pfizer join forces on potentially lucrative fatty liver disease

    Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative ...